trending Market Intelligence /marketintelligence/en/news-insights/trending/2DFUiSJGqn282-4tld484Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

AtriCure closes acquisition of SentreHEART

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


AtriCure closes acquisition of SentreHEART

AtriCure Inc. completed its acquisition of privately held SentreHEART Inc. for an up-front payment of about $40 million in a cash and stock deal.

Redwood City, Calif.-based SentreHEART develops percutaneous left atrial appendage management solutions for certain patients with an irregular heartbeat.

Mason, Ohio-based AtriCure, which develops technologies to treat atrial fibrillation, will pay an additional $140 million in milestone related payments for SentreHEART's Lariat suture delivery device and another $120 million for the therapy involving SentreHEART devices.

Piper Jaffray & Co. was the exclusive financial adviser, and Pepper Hamilton LLP served as legal counsel to ArtiCure. Guggenheim Securities LLC and Goodwin Procter LLP were SentreHEART's exclusive financial adviser and legal counsel, respectively.